Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001104659-26-105489
Filing Date
2026-09-04
Accepted
2026-09-04 16:02:09
Documents
1
Period of Report
2026-09-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2624769-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2624769-8_4seq1.xml 4 10892
  Complete submission text file 0001104659-26-105489.txt   12337
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Issuer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CHEMIN DES MINES 9 GENEVA Switzerland CH-1202
Business Address
Lawton Vincent Michael (Reporting) CIK: 0002123870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39179 | Film No.: 261362053